US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

HydrOXYzine Pamoate Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0185-0615-01 D-1046-2022
Class II · Moderate risk Terminated

Hydrocortisone Ointment USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0146-30 D-1045-2022
Class II · Moderate risk Terminated

Ciprofloxacin Ophthalmic Solution 0.3%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-656-05 D-1044-2022
Class II · Moderate risk Terminated

Lidocaine Patch 5%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0603-1880-16 D-1043-2022
Class II · Moderate risk Terminated

Olanzapine Orally Disintegrating Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-321-55 D-1042-2022
Class II · Moderate risk Terminated

ClomiPHENE Citrate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-701-55 D-1041-2022
Class II · Moderate risk Terminated

Ipratropium Bromide Inhalation Solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-9801-25 D-1040-2022
Class II · Moderate risk Terminated

Naltrexone Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0406-1170-03 D-1039-2022
Class II · Moderate risk Terminated

Glucagen

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0053-45 D-1038-2022
Class II · Moderate risk Terminated

Meclizine Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 50268-523-15 D-1037-2022
Class II · Moderate risk Terminated

Miostat

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0023-15 D-1036-2022
Class II · Moderate risk Terminated

Isopto Atropine

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0303-55 D-1035-2022
Class II · Moderate risk Terminated

BSS Sterile Irrigating Solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0795-50 D-1034-2022
Class II · Moderate risk Terminated

BSS Sterile Irrigating Solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0795-15 D-1033-2022
Class II · Moderate risk Terminated

Doxycycline Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63304-616-50 D-1032-2022
Class II · Moderate risk Terminated

Sterile Water for Injection USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0013-06 D-1031-2022
Class II · Moderate risk Terminated

Spinal Tray

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office D-1030-2022
Class II · Moderate risk Terminated

Ciprofloxacin Ophthalmic Solution 0.3%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-0656-10 D-1029-2022
Class II · Moderate risk Terminated

Betamethasone Dipropionate Cream USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0055-46 D-1028-2022
Class II · Moderate risk Terminated

Aprepitant Capsule

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2321-06 D-1027-2022
Class II · Moderate risk Terminated

Amoxicillin Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2613-01 D-1025-2022
Class II · Moderate risk Terminated

Adrenalin

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 42023-168-01 D-1022-2022